FilingReader Intelligence

Balaji Amines denies unlicensed pharma chemical production claims

October 14, 2025 at 04:59 PM UTCBy FilingReader AI

Balaji Amines Limited on October 14, 2025, addressed an Economic Times article alleging unlicensed production of pharma-grade chemicals, calling the report "baseless and misinformed." The company clarified it manufactures only technical and food-grade Propylene Glycol (PG) and does not supply pharmaceutical-grade PG for pharma applications. It highlighted that drug authorities, as per a Reuters-seen test report cited in the same article, found no evidence of contamination in Balaji's PG with ethylene or diethylene glycol, aside from expected water content.

The company stated it possesses manufacturing permission exclusively for Propylene Glycol in technical and food grades and has been producing for these specific applications. Balaji Amines also asserted that it has not received any communication from Indian authorities regarding the article's claims nor is there any ongoing investigation. The company emphasized its role as a significant import substitute producer of chemicals in India, having previously announced plans for a 15,000 tonnes per annum PG facility.

Balaji Amines underscored its commitment to the highest standards of corporate governance and regulatory compliance. It confirmed routine visits from State FDA/CDSCO teams, during which samples are collected, and reiterated that its samples have not been tested for ethylene glycol or diethylene glycol. The clarification was issued to uphold stakeholder trust and prevent unwarranted speculation.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:BALAMINESBombay Stock Exchange

News Alerts

Get instant email alerts when Balaji Amines publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →